MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT EBITDA Margin

EBITDA as a percentage of revenue.

MindWalk Holdings Corp.NASDAQ: HYFT

EBITDA Margin · Q3 FY2026 · quarter ended Jan 2026

EBITDA Margin widens to -89.7%

EBITDA Margin was -89.7% in Q3 FY2026, up 283.7 pp from a year earlier. On a trailing-twelve-month basis it was -59.3%, up 202.1 pp year over year. Over 3 fiscal years it narrowed by 55.7 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -56.1% for the fiscal year ending Apr 2026, up from -117.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJan 2026
-89.7%-17.3 pp QoQ
Last fiscal yearApr 2025
-117.7%-24.1 pp YoY
LTMJan 2026
-59.3%+202.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+283.7 pp-36.9 pp-320.6 pp
1 year-24.1 pp+61.6 pp+85.7 pp
3 years-55.7 pp+69.8 pp+125.5 pp
5 years+103.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-117.7%
Year-over-year change
-24.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How HYFT compares with its peers on the latest reported figures

  • HYFT's LTM Jan 2026 EBITDA Margin of -59.3% is the 2nd highest of the 5 companies compared; the peer median is -11560.2%.
  • Its year-over-year change of +202.1 pp is the 3rd highest of 4, against a peer median of +379.4 pp.
  • Over three fiscal years its change of -55.7 pp compares with a peer median of -5585.1 pp.
HYFT Competitors Peer median
EBITDA Margin for HYFT and competitors
Company Period LTM level YoY 3-year change
FBIOFortress Biotech, Inc.LTM Mar 2026223.7% +379.4 pp+223.8 pp
HYFTMindWalk Holdings Corp.LTM Jan 2026-59.3% +202.1 pp-55.7 pp
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026-1327.8% +2091.5 pp—
CLNNClene Inc.LTM Mar 2026-21792.5% -14931.4 pp-5585.1 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-36154.2% —-37771.8 pp
ALXOALX Oncology Holdings Inc.FY2025— ——
UNCYUnicycive Therapeutics, Inc.FY2025— ——
BYSIBeyondSpring Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding HYFT) -11560.2%+379.4 pp-5585.1 pp

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.